Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Clinical trial NCT00558337 · COMPLETED
Trial details
- NCT number
- NCT00558337
- Sponsor
- Osmotica Pharmaceutical US LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 78
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.